James P. Scanlan, Attorney at Law

Home Page

Curriculum Vitae

Publications

Published Articles

Conference Presentations

Working Papers

page1

Journal Comments

Truth in Justice Articles

Measurement Letters

Measuring Health Disp

Outline and Guide to MHD

Summary to MHD

Solutions

page3

Solutions Database

Irreducible Minimums

Pay for Performance

Between Group Variance

Concentration Index

Gini Coefficient

Reporting Heterogeneity

Cohort Considerations

Relative v Absolute Diff

Whitehall Studies

AHRQ's Vanderbilt Report

NHDR Measurement

NHDR Technical Issues

MHD A Articles

MHD B Conf Presentations

MHD D Journal Comments

Consensus/Non-Consensus

Spurious Contradictions

Institutional Corresp

page2

Scanlan's Rule

Outline and Guide to SR

Summary to SR

Bibliography

Semantic Issues

Employment Tests

Case Study

Case Study Answers

Case Study II

Subgroup Effects

Subgroup Effects NC

Illogical Premises

Illogical Premises II

Inevitable Interaction

Interactions by Age

Literacy Illustration

RERI

Feminization of Poverty S

Explanatory Theories

Mortality and Survival

Truncation Issues

Collected Illustrations

Income Illustrations

Framingham Illustrations

Life Table Illustrations

NHANES Illustrations

Mort/Surv Illustration

Credit Score Illustration

Intermediate Outcomes

Representational Disp

Statistical Signif SR

Comparing Averages

Meta-Analysis

Case Control Studies

Criminal Record Effects

Sears Case Illustration

Numeracy Illustration

Obesity Illusration

LIHTC Approval Disparitie

Recidivism Illustration

Consensus

Algorithm Fairness

Mortality and Survival 2

Mort/Survival Update

Measures of Association

Immunization Disparities

Race Health Initiative

Educational Disparities

Disparities by Subject

CUNY ISLG Eq Indicators

Harvard CRP NCLB Study

New York Proficiency Disp

Education Trust GC Study

Education Trust HA Study

AE Casey Profic Study

McKinsey Achiev Gap Study

California RICA

Nuclear Deterrence

Employment Discrimination

Job Segregation

Measuring Hiring Discr

Disparate Impact

Four-Fifths Rule

Less Discr Alt - Proc

Less Discr Altl - Subs

Fisher v. Transco Serv

Jones v. City of Boston

Bottom Line Issue

Lending Disparities

Inc & Cred Score Example

Disparities - High Income

Underadjustment Issues

Absolute Differences - L

Lathern v. NationsBank

US v. Countrywide

US v. Wells Fargo

Partial Picture Issues

Foreclosure Disparities

File Comparison Issues

FHA/VA Steering Study

CAP TARP Study

Disparities by Sector

Holder/Perez Letter

Federal Reserve Letter

Discipline Disparities

COPAA v. DeVos

Kerri K. V. California

Truancy Illustration

Disparate Treatment

Relative Absolute Diff

Offense Type Issues

Los Angeles SWPBS

Oakland Disparities

Richmond Disparities

Nashville Disparities

California Disparities

Denver Disparities

Colorado Disparities

Nor Carolina Disparitie

Aurora Disparities

Allegheny County Disp

Evansville Disparities

Maryland Disparities

St. Paul Disparities

Seattle Disparities

Minneapolis Disparities

Oregon Disparities

Beaverton Disparities

Montgomery County Disp

Henrico County Disparitie

Florida Disparities

Connecticut Disparities

Portland Disparities

Minnesota Disparities

Massachusetts Disparities

Rhode Island Disparities

South Bend Disparities

Utah Disparities

Loudoun Cty Disparities

Kern County Disparities

Milwaukee Disparities

Urbana Disparities

Illinois Disparities

Virginia Disparities

Behavior

Suburban Disparities

Preschool Disparities

Restraint Disparities

Disabilities - PL 108-446

Keep Kids in School Act

Gender Disparities

Ferguson Arrest Disp

NEPC Colorado Study

NEPC National Study

California Prison Pop

APA Zero Tolerance Study

Flawed Inferences - Disc

Oakland Agreement

DOE Equity Report

IDEA Data Center Guide

Duncan/Ali Letter

Crim Justice Disparities

U.S. Customs Search Disp

Deescalation Training

Career Criminal Study

Implicit Bias Training

Drawing Inferences

Diversion Programs

Minneapolis PD Investig

Offense Type Issues CJD

Innumerate Decree Monitor

Massachusetts CJ Disparit

Feminization of Poverty

Affirmative Action

Affirm Action for Women

Other Affirm Action

Justice John Paul Stevens

Statistical Reasoning

The Sears Case

Sears Case Documents

The AT&T Consent Decree

Cross v. ASPI

Vignettes

Times Higher Issues

Gender Diff in DADT Term

Adjustment Issues

Percentage Points

Odds Ratios

Statistical Signif Vig

Journalists & Statistics

Multiplication Definition

Prosecutorial Misconduct

Outline and Guide

Misconduct Summary

B1 Agent Cain Testimony

B1a Bev Wilsh Diversion

B2 Bk Entry re Cain Call

B3 John Mitchell Count

B3a Obscuring Msg Slips

B3b Missing Barksdale Int

B4 Park Towers

B5 Dean 1997 Motion

B6 Demery Testimony

B7 Sankin Receipts

B7a Sankin HBS App

B8 DOJ Complicity

B9 Doc Manager Complaints

B9a Fabricated Gov Exh 25

B11a DC Bar Complaint

Letters (Misconduct)

Links Page

Misconduct Profiles

Arlin M. Adams

Jo Ann Harris

Bruce C. Swartz

Swartz Addendum 2

Swartz Addendum 3

Swartz Addendum 4

Swartz Addendum 7

Robert E. O'Neill

O'Neill Addendum 7

Paula A. Sweeney

Robert J. Meyer

Lantos Hearings

Password Protected

OIC Doc Manager Material

DC Bar Materials

Temp Confidential

DV Issues

Indexes

Document Storage

Pre 1989

1989 - present

Presentations

Prosec Misc Docs

Prosec Misc Docs II

Profile PDFs

Misc Letters July 2008 on

Large Prosec Misc Docs

HUD Documents

Transcripts

Miscellaneous Documents

Unpublished Papers

Letters re MHD

Tables

MHD Comments

Figures

ASPI Documents

Web Page PDFs

Sears Documents

Pages Transfer


IMMUNIZATION DISPARITIES

[VACCINATION DISPARITIES, IMMUNIZATION INEQUALITIES,

VACCINATION INEQUALITIES]

(Jan. 15, 2011; rev. Feb. 7, 2012)


This item discusses measurement issues related to demographic disparities in immunization.  But the points made could apply to a wide range of healthcare disparities issues, particularly those that are studied using a variety of methods and those that involve rate ranges where the statistical forces described in the Scanlan’s Rule page could tend toward causing absolute differences and differences measured by odds ratio to either increase or decrease as overall prevalence of the outcome changes and where the changes in prevalence may cause the determination of which relative difference is larger to change over time.[i]  Among particularly relevant related items on this site are the Pay-for-Performance sub-page of the Measuring Health Disparities page (MHD) and the Mortality and Survival page.  The former discusses the way that reliance on absolute differences between rates as a measure of healthcare disparities has led observers in the United States to believe that pay-for-performance will tend to increase healthcare disparities and observers in the United Kingdom to believe that pay-for-performance will tend to reduce healthcare disparities.  The latter discusses a variety of issues (both as to survival/mortality and screening/non-screening) concerning confusion regarding disparities in adverse and favorable outcomes including the tendency to discuss relative differences in one outcome (both as to survival issues and screening) while in fact analyzing relative differences in the opposite outcome and to do so without recognizing that the two relative differences tend to change systematically in opposite directions as the prevalence of an outcome changes.  Also relevant are Sections E.4 and E.7 of MHD and A.6 of the Scanlan’s Rule page, as well the APHA 2007 presentation,[ii] which discuss the measurement approaches of National Center for Health Statistics (NCHS) and the Agency for Healthcare and Research and Quality (AHRQ). 

Immunization disparities are studied in terms of relative differences in immunization rates, relative differences in failure to be immunized, absolute differences, and odds ratios.  Universally, however, researchers employing these methods have done so without recognizing the way that the measure tends to be affected by the overall prevalence of an outcome and almost invariably without regard to whether other measures would yield contrary results as to direction of change over time. 

The issue is nicely illustrated with data from a 2008 Pediatrics study by Morita et al[iii] that examined the effects on racial and ethnic disparities of a school-entry Hepatitis B vaccination requirement.  Relying on relative differences in vaccination rates to measure disparities, the authors found that the requirement, which dramatically increased overall vaccination rates, also dramatically reduced racial and ethnic vaccination disparities.  But the National Center for Health Statistics (NCHS), which measures all disparities in terms of relative differences in adverse outcomes (including, in the case of procedures like vaccination, failure to receive the procedure), would find the disparity to have increased dramatically. 

The patterns are illustrated in the Tables A and B below.  They are taken from Comment on Morita,[iv] which discusses the patterns in greater detail, including the changes in absolute differences and the way different researchers would reach different conclusions based on the choice of measure.  It also appraises the changes in the disparities according to the procedure describe on the Solutions sub-page of MHD. 

Table A:  White and Black Vaccination Rates and Rates of not being Vaccinated Before and After Implementation of School-Entry Vaccination Requirement, with Relative and Absolute Differences, Odds Ratios, and Estimated Effect Size (based on data from Morita et al.)

 

 

Grade

Year

Program

WY

BY

WN

BN

RelFav

RelAdv

AD

OR

EES

5

1996

Pre

8%

3%

92%

97%

62.50%

5.43%

5

2.81

47

5

1997

Post

46%

33%

54%

67%

28.26%

24.07%

13

1.73

34

5

1998

Post

50%

39%

50%

61%

22.00%

22.00%

11

1.56

29

9

1996

Pre

46%

32%

54%

68%

30.43%

25.93%

14

1.81

37

9

1997

Post

89%

84%

11%

16%

5.62%

45.45%

5

1.54

24

9

1998

Post

93%

89%

7%

11%

4.30%

57.14%

4

1.64

26

 

Table B:  White and Hispanic Vaccination Rates and Rates of not being Vaccinated Before and After Implementation of School-Entry Vaccination Requirement, with Relative and Absolute Differences, Odds Ratios, and Estimated Effect Size (based on data from Morita et al.)

 

 

Grade

Year

Program

WY

HY

WN

HN

RelFav

RelAdv

AD

OR

EES

5

1996

Pre

8%

4%

92%

96%

50.00%

4.35%

4

2.09

34

5

1997

Post

46%

42%

54%

58%

8.70%

7.41%

4

1.18

10

5

1998

Post

50%

51%

50%

49%

-2.00%

-2.00%

1

0.96

1

9

1996

Pre

46%

40%

54%

60%

13.04%

11.11%

6

1.28

15

9

1997

Post

89%

86%

11%

14%

3.37%

27.27%

3

1.32

15

9

1998

Post

93%

93%

7%

7%

0.00%

0.00%

0

1.00

1

 

A few other studies that recently caught my attention warrant mention as well.  I note, however, that the points made about them could be made about countless other studies of disparities in immunization and other healthcare procedures.  In fact, the points generally could be made about almost all health and healthcare disparities studies.

A recent study by Zhao and Luman[v]) in the American Journal of Preventive Medicine relied on absolute differences between rates as a measure of immunization disparities in finding general decreases in disparities during a period of overall increases in immunization rates.  The study is of particular note because the authors are from the Centers for Disease Control and Prevention (CDC), of which NCHS is a part.  Relying on relative differences in failure to be vaccinated, NCHS would have found increasing disparities in 8 of the 12 unadjusted analyses and 7 of the 12 adjusted analyses.

A table that may be found here (which is based on data in Table 1 from Zhao and Luman) illustrates these patterns as well as the other patterns of changes in standard measures.  It also shows, using the method described in the Solutions sub-page of MHD, that usually the disparities decreased in a meaningful sense.  But in a few cases, though the absolute differences decreased slightly, the disparity actually increased slightly.

Apparently, the ignoring of the NCHS recommendation to measure all disparities in terms of relative differences in adverse outcomes is common at the CDC.  On January 14, 2010, CDC released the CDC Health Disparities and Inequalities Report ­– United States, 2011.  The report generally relies on absolute differences between rates for the measurement of healthcare disparities, including immunization disparities (and screening disparities).  There is some overlap of the report with AHRQ’s National Healthcare Disparities Report.  Given that AHRQ relies on the larger of two relative differences to measure disparities, and that as the prevalence of an outcome changes the absolute difference tends to change in the same direction as the smaller of the two absolute differences, there will be a tendency for CDC to reach conclusions about the directions of changes in the size of disparities over time that are the opposite of those AHRQ would reach.[vi] 

A 2010 study by Yoo et al.[vii] in American Journal of Preventive Medicine also relied on absolute differences between rates as a measure of disparity without consideration of the implications of overall prevalence.   In the main, the authors found that during periods of vaccine shortage, when overall vaccination rates decreased, absolute differences between rates increased; during period periods of adequate supply when overall vaccination rates increased, absolute differences decreased.  But, for the most part, the vaccination rates for the affected groups were in ranges where, as discussed in the introduction to the Scanlan’s Rule page, overall increase will tend to decreases absolute differences and overall decreases will tend to increase absolute differences.

The Yoo data show some exceptions to this pattern.  And no doubt in many cases the directions of changes in absolute differences would comport with the directions of changes in disparities that one would find by the method described on the Solutions sub-page of MHD.  But one cannot usefully measure changes in disparities by simply relying on changes in absolute differences – or changes in any other standard measures of difference between rates – without consideration of the way the measure tends to be affected by the overall prevalence of an outcome.

An article by Niederhauser and Stark,[viii] which broadly discussed immunization disparities, presented in its Table 2 information (drawn from Klevens and Luman[ix] on various vaccination rates for children 19-35 months (a) above the poverty line, (b) in near poverty, (c) in intermediate poverty, and (d) in severe poverty.  Table C below presents the vaccination rates for those above the poverty line (AP) and for those in (SP) severe poverty, while presenting the same measures shown Tables A and B above.

Table C:  Vaccination Rates and Rates of not being Vaccinated by Type of Vaccination for Children 19-35 Months above the Poverty Line (AP) and in Severe Poverty (SP), with Relative and Absolute Differences, Odds Ratios, and Estimated Effect Size (based on data from Niederhauser and Stark et al.)

 

Vac_Type

APY

SPY

APN

SPN

RelFav

RelAdv

AD

OR

EES

DTP-4 doses

86.10%

77.80%

13.90%

22.20%

9.64%

59.71%

8.30%

1.77

0.32

Polio-3 doses

90.80%

87.00%

9.20%

13.00%

4.19%

41.30%

3.80%

1.47

0.22

HIB-3 doses

93.00%

88.20%

7.00%

11.80%

5.16%

68.57%

4.80%

1.78

0.29

MCV-1 dose

95.30%

89.70%

4.70%

10.30%

5.88%

119.15%

5.60%

2.33

0.42

Hepatitis B-3 doses

89.20%

84.50%

10.80%

15.50%

5.27%

43.52%

4.70%

1.52

0.22

Varicella-1 dose

58.50%

52.10%

41.50%

47.90%

10.94%

15.42%

6.40%

1.30

0.18

 

A recent book published by the World Bank, Attacking Inequality in the Health Sector: A Synthesis of Evidence and Tools,[x] warrants mention for its analysis of immunization disparities in terms of relative differences in immunization rates.  Like Morita et al., it employs what many would regard as the standard approach to measurement of immunization disparities, and is reflective of the unlikelihood that the NCHS approach will have great influence (as discussed with regard to the United Kingdom in Section [2] of the Mortality and Survival page).  Of, course as discussed above, even CDC seems not to be following the NCHS recommendation. 

A paper presented at the 2010 European Population Conference by Gupta and Sekher[xi] is interesting because the authors analyzed both relative differences in favorable outcomes and relative differences in adverse outcomes.  The authors analyzed relative differences in favorable outcomes with respect to the receipt of full immunization and relative differences in adverse outcomes with respect to failure to receive any immunization.  The patterns in data they provide in an extended abstract are not particularly consistent with the patterns I discuss here and elsewhere on this site.  But there nevertheless is reason to expect that generally overall increases in immunization will tend to reduce relative differences in full immunization but increase relative differences in failure to receive any immunization (while increasing relative differences in the failure to receive full immunization and reducing relative differences in receiving some immunization).  


[i] By way of broad summary, as an outcome increases in overall prevalence, relative differences in experiencing it tend to decrease while relative differences in failing to experience it tend to tend to increase.  As rates that are less than 50% for both groups increase, absolute differences between rates tend to increase; as rates that are greater than 50% for both groups increase, absolute differences tend to decrease.  Differences measured by odds ratios tend to change in the opposite direction of the absolute difference. 

 [ii]  Scanlan JP. Measurement Problems in the National Healthcare Disparities Report, presented at American Public Health Association 135th Annual Meeting & Exposition, Washington, DC, Nov. 3-7, 2007: PowerPoint Presentation:  http://www.jpscanlan.com/images/APHA_2007_Presentation.ppt;        Oral Presentation:  http://www.jpscanlan.com/images/ORAL_ANNOTATED.pdf; Addendum (March 11, 2008): http://www.jpscanlan.com/images/Addendum.pdf

[iii] Morita JY, Ramirez E, Trick WE. Effect of school-entry vaccination requirements on racial and ethnic disparities in Hepatitis B immunization coverage among public high school students. Pediatrics 2008;121:e547-e552

[iv] Scanlan JP.  Study illustrates ways in which the direction of a change in disparity turns on the measure chosen.  Pediatrics Mar 27, 2008 (responding to Morita JY, Ramirez E, Trick WE. Effect of school-entry vaccination requirements on racial and ethnic disparities in Hepatitis B immunization coverage among public high school students. Pediatrics 2008;121:e547-e552): http://pediatrics.aappublications.org/cgi/eletters/121/3/e547

[v] Zhao Z, Luman ET.  Progress toward eliminating disparities in vaccination coverage among U.S. Children 2000-2008.  Am J Prev Med 2010;xx(x);xxx

[vi]  Extended discussion of another instance of reliance on absolute differences as a measure of immunization disparities may be found in Scanlan JP.  Understanding patterns of absolute differences in vaccination rates in different settings. Journal Review Apr. 22, 2008 (responding to Schneider EC, Cleary PD, Zaslavsky AM, Epstein AM.  Racial disparity in influenza vaccination:  Does managed care narrow the gap between blacks and whites?  JAMA 2001;286:1455-1460): http://journalreview.org/v2/articles/view/11572737.html

[vii] Yoo B-K, Kasajima M, Phelps CE, et al.  Influenza vaccine supply and racial/ethnic disparities in vaccination rates.  Am J Prev Med 2011;40(1):1-10.

 [viii] Niederhauser VP, Starke M.  Narrowing the gap in childhood immunization disparities.  Pediatric Nursing 2005;31(5):380-386: http://www.pediatricnursing.net/ce/2007/article10380388.pdf

[ix] Klevens, R.M., & Luman, E.T.  U.S. children living in and near poverty: Risk of vaccine-preventable diseases. Am J Prev Med 2001;20(4 Suppl);41-46.

 [x] Yazbeck, Abdo S. Attacking Inequality in the Health Sector, A Synthesis of Evidence and Tools, World Bank, Washington: 2010.

 [xi]  Gupta A, Sekher TV.   Inequalities in Childhood Immunization in India – A National Level Analysis of Policy Concerns, presented at European Population Conference 2010, Vienna, Austria, Sept. 1-3, 2010: http://epc2010.princeton.edu/abstractViewer.aspx?submissionId=100758